Thursday, April 25, 2024

April 26, 2024 at 12:07AM TECARTUS

For the treatment of adult patients with relapsed or refractory (r/r) B-cell precursor acute lymphoblastic leukemia (B-ALL). For the treatment of adult patients with relapsed/refractory mantle cell lymphoma (r/r MCL).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/gFWBVZ8

No comments:

Post a Comment